Cargando…

Adverse effects of isoniazid preventative therapy for latent tuberculosis infection: a prospective cohort study

INTRODUCTION: Isoniazid preventative therapy (IPT) is a widely used intervention for treatment of latent tuberculosis infection (LTBI), particularly in patients at high risk for reactivation. While treatment-limiting adverse effects have been well studied, few prospective studies have considered the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Denholm, Justin T, McBryde, Emma S, Eisen, Damon P, Penington, Jocelyn S, Chen, Caroline, Street, Alan C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2014
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4211866/ https://www.ncbi.nlm.nih.gov/pubmed/25364275 http://dx.doi.org/10.2147/DHPS.S68837

Ejemplares similares

The use of anti-tuberculosis therapy for latent TB infection
por: Denholm, Justin T, et al.
Publicado: (2010)

Management of Latent Tuberculosis Infections in Australia and New Zealand: A Review of Current Practice
por: Denholm, Justin T., et al.
Publicado: (2010)

Interferon-gamma release assay for the diagnosis of latent tuberculosis infection: A latent-class analysis
por: Doan, Tan N., et al.
Publicado: (2017)

The role of geospatial hotspots in the spatial spread of tuberculosis in rural Ethiopia: a mathematical model
por: Shaweno, Debebe, et al.
Publicado: (2018)

A novel Bayesian geospatial method for estimating tuberculosis incidence reveals many missed TB cases in Ethiopia
por: Shaweno, Debebe, et al.
Publicado: (2017)

High rates of multidrug-resistant and rifampicin-resistant tuberculosis among re-treatment cases: where do they come from?
por: Ragonnet, Romain, et al.
Publicado: (2017)

A user-friendly mathematical modelling web interface to assist local decision making in the fight against drug-resistant tuberculosis
por: Ragonnet, Romain, et al.
Publicado: (2017)

Tropical Australian Health-Data Linkage Shows Excess Mortality Following Severe Infectious Disease Is Present in the Short-Term and Long-Term after Hospital Discharge
por: Adegboye, Oyelola A., et al.
Publicado: (2021)

Critical Consideration of Tuberculosis Management of Papua New Guinea Nationals and Cross-Border Health Issues in the Remote Torres Strait Islands, Australia
por: Foster, J’Belle, et al.
Publicado: (2022)

Estimating the long-term effects of mass screening for latent and active tuberculosis in the Marshall Islands
por: Ragonnet, Romain, et al.
Publicado: (2022)

Linking administrative data sets of inpatient infectious diseases diagnoses in far North Queensland: a cohort profile
por: Eisen, Damon P, et al.
Publicado: (2020)

The role of super-spreading events in Mycobacterium tuberculosis transmission: evidence from contact tracing
por: Melsew, Yayehirad A., et al.
Publicado: (2019)

Methods used in the spatial analysis of tuberculosis epidemiology: a systematic review
por: Shaweno, Debebe, et al.
Publicado: (2018)

TB incidence and characteristics in the remote gulf province of Papua New Guinea: a prospective study
por: Cross, Gail B, et al.
Publicado: (2014)

Modelling the effect of short-course multidrug-resistant tuberculosis treatment in Karakalpakstan, Uzbekistan
por: Trauer, James M., et al.
Publicado: (2016)

Do Active Surveillance and Contact Precautions Reduce MRSA Acquisition? A Prospective Interrupted Time Series
por: Marshall, Caroline, et al.
Publicado: (2013)

Vaccination Programs for Endemic Infections: Modelling Real versus Apparent Impacts of Vaccine and Infection Characteristics
por: Ragonnet, Romain, et al.
Publicado: (2015)

Effect of isoniazid on antigen-specific interferon-γ secretion in latent tuberculosis
por: Torres, Martha, et al.
Publicado: (2015)

1694 Risk factors and outcomes of isoniazid hepatotoxicity in children with latent tuberculosis
por: Devrim, Ilker, et al.
Publicado: (2014)

Treatment completion for latent tuberculosis infection: a retrospective cohort study comparing 9 months of isoniazid, 4 months of rifampin and 3 months of isoniazid and rifapentine
por: McClintock, Adelaide H., et al.
Publicado: (2017)

Economic Consequences of the COVID-19 Outbreak: the Need for Epidemic Preparedness
por: Pak, Anton, et al.
Publicado: (2020)

Seizures in an Immunocompetent Adult From Treatment of Latent Tuberculosis Infection: Is Isoniazid to Blame?
por: Navalkele, Bhagyashri, et al.
Publicado: (2020)

Cost effectiveness of three months of rifapentine and isoniazid for latent tuberculosis in Syrian refugees
por: Ilaiwy, Ghassan, et al.
Publicado: (2021)

Hepatotoxicity induced by isoniazid in patients with latent tuberculosis infection: a meta-analysis
por: Oscanoa, Teodoro J., et al.
Publicado: (2023)

Isoniazid Prophylaxis for Latent Tuberculosis Infections in Liver Transplant Recipients in a Tuberculosis-Endemic Area
por: Moon, Hyung Hwan, et al.
Publicado: (2017)

Is IPT more effective in high-burden settings? Modelling the effect of tuberculosis incidence on IPT impact
por: Ragonnet, R., et al.
Publicado: (2017)

Association of Drug Metabolic Enzyme Genetic Polymorphisms and Adverse Drug Reactions in Patients Receiving Rifapentine and Isoniazid Therapy for Latent Tuberculosis
por: Yu, Ya-Yen, et al.
Publicado: (2019)

Isoniazid-Induced Severe Hepatotoxicity: An Infrequent but Preventable Cause of Liver Failure in Children Treated for Latent Tuberculosis Infection
por: Desrochers, Dan, et al.
Publicado: (2011)

Cost-effectiveness of 3-months isoniazid and rifapentine compared to 9-months isoniazid for latent tuberculosis infection: a systematic review
por: Lai, Wendy A., et al.
Publicado: (2022)

The role of Staphylococcus aureus carriage in the pathogenesis of bloodstream infection
por: Marshall, Caroline, et al.
Publicado: (2014)

Isoniazid Preventive Therapy and Risk for Resistant Tuberculosis
por: Balcells, Maria Elvira, et al.
Publicado: (2006)

Isoniazid for preventing tuberculosis in HIV‐infected children
por: Zunza, Moleen, et al.
Publicado: (2017)

Profiling Mycobacterium tuberculosis transmission and the resulting disease burden in the five highest tuberculosis burden countries
por: Ragonnet, Romain, et al.
Publicado: (2019)

Adherence to nine-month isoniazid for latent tuberculosis infection in healthcare workers: a prospective study in a tertiary hospital
por: Chung, Sung Jun, et al.
Publicado: (2020)

Plasma Concentrations of sTREM-1 as Markers for Systemic Adverse Reactions in Subjects Treated With Weekly Rifapentine and Isoniazid for Latent Tuberculosis Infection
por: Wang, Tsai-Yu, et al.
Publicado: (2022)

Adverse Events of Latent Tuberculosis Treatment With Isoniazid in People Living With HIV: A Case-Control Study in a Resource-Rich Setting
por: Carlos Silveira Machado, António, et al.
Publicado: (2023)

A Case of Acute Liver Failure in a Patient on Isoniazid Prophylaxis for Latent Tuberculosis
por: Philipose, Jobin, et al.
Publicado: (2022)

Delay effect and burden of weather-related tuberculosis cases in Rajshahi province, Bangladesh, 2007–2012
por: Kuddus, Md Abdul, et al.
Publicado: (2019)

The value of early transmission dynamic studies in emerging infectious diseases
por: McBryde, Emma
Publicado: (2020)

Cost-Effectiveness of isoniazid preventive therapy among HIV-infected patients clinicaly screened for latent tuberculosis infection in Dar es Salaam, Tanzania: A prospective Cohort study
por: Shayo, Grace A., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_127avkn13rrteserg58v685qv6